BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home » Authors » John Fox

Articles by John Fox

Compound accelerates post-stroke motor function recovery

April 9, 2018
By John Fox
HONG KONG – A neural plasticity enhancer, edonerpic maleate, could be the first clinically effective compound for accelerating rehabilitation after brain damage, potentially revolutionizing the future management of stroke patients, according to the results of a new Japanese study reported in the April 6, 2018, edition of Science.
Read More

Autophagy role in memory may yield anxiety treatments

April 4, 2018
By John Fox
HONG KONG – The discovery that autophagy can enhance erasure of memory suggests that autophagy inducers could represent a useful new therapeutic tool for treating common chronic anxiety-associated conditions in individuals with post-traumatic stress disorder (PTSD).
Read More

Autophagy role in memory may yield anxiety treatments

April 2, 2018
By John Fox

Autophagy role in memory may yield anxiety treatments

April 2, 2018
By John Fox
The discovery that autophagy can enhance erasure of memory suggests that autophagy inducers could represent a useful new therapeutic tool for treating common chronic anxiety-associated conditions in individuals with post-traumatic stress disorder (PTSD).
Read More

Gut microbiome and dietary fiber may hold diabetes key

March 21, 2018
By John Fox
HONG KONG – A guild of gut bacteria that helped to alleviate the symptoms of type 2 diabetes mellitus (T2DM) in patients receiving a high-fiber diet, has been identified in a randomized clinical trial performed in China.
Read More

Gut microbiome and dietary fiber may hold diabetes key

March 20, 2018
By John Fox

Stem cells may hold promise of diabetes cure

March 14, 2018
By John Fox
HONG KONG – Scientists at the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have for the first time confirmed the existence of human pancreatic progenitor cells and have shown they can be induced to develop into glucose-responsive pancreatic beta cells.
Read More

Stem cells may hold promise of diabetes cure

March 12, 2018
By John Fox
HONG KONG – Scientists at the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have for the first time confirmed the existence of human pancreatic progenitor cells and have shown they can be induced to develop into glucose-responsive pancreatic beta cells.
Read More

Stem cells may hold the promise of diabetes cure

March 9, 2018
By John Fox

Ketamine discovery may yield fast-acting antidepressants

March 7, 2018
By John Fox
HONG KONG – A Chinese study has shown for the first time that the powerful antidepressant effects of ketamine are due to blockade of rapid neuronal firing in the brain's lateral habenula (LHb) region. Such blockade was found to disinhibit reward centers and relieve depressive symptoms rapidly in animal models.
Read More
Previous 1 2 … 23 24 25 26 27 28 29 30 31 … 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 6, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • DNA, dollars illustration

    Latus Bio series A financing supports early-stage programs

    BioWorld Science

    Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...

  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing